- Patent Title: Isoflavonoid compositions and methods for the treatment of cancer
-
Application No.: US13881599Application Date: 2011-11-01
-
Publication No.: US09708283B2Publication Date: 2017-07-18
- Inventor: Ofir Moreno
- Applicant: Ofir Moreno
- Applicant Address: US CA San Diego
- Assignee: MEI PHARMA, INC.
- Current Assignee: MEI PHARMA, INC.
- Current Assignee Address: US CA San Diego
- Agency: Wilson Sonsini Goodrich & Rosati
- International Application: PCT/US2011/058820 WO 20111101
- International Announcement: WO2012/061413 WO 20120510
- Main IPC: C07D311/58
- IPC: C07D311/58 ; A61K31/353 ; A61K47/40 ; A61P35/00 ; A61K31/337 ; A61K31/555 ; A61K33/24 ; A61K45/06 ; A61K9/00 ; A61K9/51
Abstract:
Provided herein is a pharmaceutical composition comprising an isoflavonoid derivative and a cyclodextrin. Also provided herein are methods of treating cancer, sensitizing cancer cells, and inducing apoptosis in cancer cells by administering such compositions. In specific instances, provided herein are intravenous compositions and therapies.
Public/Granted literature
- US20130273177A1 ISOFLAVONOID COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER Public/Granted day:2013-10-17
Information query
